Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/04/2026 ,inter alia, to consider and approve a proposal of demerger of ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Indrayani Biotech Ltd has informed BSE that its Board of Directors will meet on 9th April 2026 to consider and evaluate a proposal for the demerger of one of its units into a separate entity. The stated objective is to unlock shareholder value. The trading window for dealing in the company's securities remains closed until 48 hours after the upcoming financial results are declared. No further details such as the demerger ratio, the name of the unit involved, or the resulting entity have been disclosed in this intimation.
This is a preliminary intimation — no concrete demerger terms have been announced yet, so there is limited immediate impact on shareholders. Investors should watch for the outcome of the 9th April board meeting, where key details like the swap ratio, structure, and timeline are likely to be disclosed.